• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌中的乳腺黏蛋白MUCI作为内皮细胞间黏附分子1的新型黏附配体。

The breast mucin MUCI as a novel adhesion ligand for endothelial intercellular adhesion molecule 1 in breast cancer.

作者信息

Regimbald L H, Pilarski L M, Longenecker B M, Reddish M A, Zimmermann G, Hugh J C

机构信息

Department of Laboratory Medicine, Cross Cancer Institute, Edmonton, Alberta, Canada.

出版信息

Cancer Res. 1996 Sep 15;56(18):4244-9.

PMID:8797599
Abstract

The MUC 1 mucin is expressed on normal breast epithelium and in 90% of breast cancers. We report here that tumor-associated MUC1 is a ligand for intercellular adhesion molecule 1 (ICAM-1). Antibodies to ICAM-1 and to MUC1 inhibited adhesion of human and transfected mouse MUC1-positive cell lines to human umbilical vein endothelial cell monolayers and immobilized recombinant human ICAM-1-immunoglobulin fusion protein. Purified MUC1 pretreatment of recombinant human ICAM-1 was an equally effective inhibitor of adhesion. The interaction between MUC1 and ICAM-1 may be critical to the process of bloodborne metastases in breast cancer.

摘要

MUC1黏蛋白在正常乳腺上皮及90%的乳腺癌中表达。我们在此报告,肿瘤相关的MUC1是细胞间黏附分子1(ICAM-1)的配体。针对ICAM-1和MUC1的抗体抑制了人和转染的小鼠MUC1阳性细胞系与人脐静脉内皮细胞单层以及固定化重组人ICAM-1免疫球蛋白融合蛋白的黏附。重组人ICAM-1经纯化的MUC1预处理同样是有效的黏附抑制剂。MUC1与ICAM-1之间的相互作用可能对乳腺癌血行转移过程至关重要。

相似文献

1
The breast mucin MUCI as a novel adhesion ligand for endothelial intercellular adhesion molecule 1 in breast cancer.乳腺癌中的乳腺黏蛋白MUCI作为内皮细胞间黏附分子1的新型黏附配体。
Cancer Res. 1996 Sep 15;56(18):4244-9.
2
MUC1 synthetic peptide inhibition of intercellular adhesion molecule-1 and MUC1 binding requires six tandem repeats.MUC1合成肽对细胞间黏附分子-1的抑制作用以及MUC1结合需要六个串联重复序列。
Cancer Res. 1998 Dec 1;58(23):5577-81.
3
Tanshinone I suppresses growth and invasion of human breast cancer cells, MDA-MB-231, through regulation of adhesion molecules.丹参酮 I 通过调节黏附分子抑制人乳腺癌细胞 MDA-MB-231 的生长和侵袭。
Carcinogenesis. 2008 Oct;29(10):1885-92. doi: 10.1093/carcin/bgn151. Epub 2008 Jun 26.
4
MUC1 initiates Src-CrkL-Rac1/Cdc42-mediated actin cytoskeletal protrusive motility after ligating intercellular adhesion molecule-1.在连接细胞间黏附分子-1后,MUC1启动Src-CrkL-Rac1/Cdc42介导的肌动蛋白细胞骨架突出运动。
Mol Cancer Res. 2008 Apr;6(4):555-67. doi: 10.1158/1541-7786.MCR-07-2033.
5
In vitro assessment of adhesion molecules expression by human endothelial cells cocultured with c-erbB2-positive and c-erbB2-negative breast carcinoma cell lines.
Pol J Pathol. 2008;59(1):49-54.
6
Serum galectin-2, -4, and -8 are greatly increased in colon and breast cancer patients and promote cancer cell adhesion to blood vascular endothelium.血清半乳糖凝集素-2、-4 和-8 在结肠癌和乳腺癌患者中显著增加,并促进癌细胞黏附至血管内皮细胞。
Clin Cancer Res. 2011 Nov 15;17(22):7035-46. doi: 10.1158/1078-0432.CCR-11-1462. Epub 2011 Sep 20.
7
Cooperative role of E-cadherin and sialyl-Lewis X/A-deficient MUC1 in the passive dissemination of tumor emboli in inflammatory breast carcinoma.E-钙黏蛋白和唾液酸化路易斯X/A缺陷型MUC1在炎性乳腺癌肿瘤栓子被动播散中的协同作用
Oncogene. 2002 May 16;21(22):3631-43. doi: 10.1038/sj.onc.1205389.
8
MUC1 mediates transendothelial migration in vitro by ligating endothelial cell ICAM-1.MUC1通过连接内皮细胞ICAM-1在体外介导跨内皮迁移。
Clin Exp Metastasis. 2005;22(6):475-83. doi: 10.1007/s10585-005-3098-x.
9
Immunity to murine breast cancer cells modified to express MUC-1, a human breast cancer antigen, in transgenic mice tolerant to human MUC-1.在对人MUC-1耐受的转基因小鼠中,对经修饰以表达人乳腺癌抗原MUC-1的鼠乳腺癌细胞的免疫反应。
Cancer Res. 2000 May 1;60(9):2435-43.
10
Synergistic stimulation of MUC1 expression in normal breast epithelia and breast cancer cells by interferon-gamma and tumor necrosis factor-alpha.干扰素-γ和肿瘤坏死因子-α对正常乳腺上皮细胞和乳腺癌细胞中MUC1表达的协同刺激作用。
J Cell Biochem. 2002;86(4):759-72. doi: 10.1002/jcb.10261.

引用本文的文献

1
ICAM-1 nanoclusters regulate hepatic epithelial cell polarity by leukocyte adhesion-independent control of apical actomyosin.ICAM-1 纳米簇通过白细胞黏附非依赖性调控顶端肌动球蛋白来调节肝上皮细胞极性。
Elife. 2024 Apr 10;12:RP89261. doi: 10.7554/eLife.89261.
2
Blood biomarkers for canine cancer, from human to veterinary oncology.犬类癌症的血液生物标志物:从人类肿瘤学到兽医肿瘤学。
Vet Comp Oncol. 2022 Dec;20(4):767-777. doi: 10.1111/vco.12848. Epub 2022 Jul 20.
3
Mucin1 and Mucin16: Therapeutic Targets for Cancer Therapy.黏蛋白1和黏蛋白16:癌症治疗的靶点
Pharmaceuticals (Basel). 2021 Oct 17;14(10):1053. doi: 10.3390/ph14101053.
4
Innovations in Biomaterial Design toward Successful RNA Interference Therapy for Cancer Treatment.生物材料设计的创新,实现癌症治疗的 RNA 干扰疗法的成功。
Adv Healthc Mater. 2021 Jul;10(13):e2100350. doi: 10.1002/adhm.202100350. Epub 2021 May 11.
5
Potential of Anti-MUC1 Antibodies as a Targeted Therapy for Gastrointestinal Cancers.抗MUC1抗体作为胃肠道癌症靶向治疗的潜力
Vaccines (Basel). 2020 Nov 5;8(4):659. doi: 10.3390/vaccines8040659.
6
Novel Antibodies Targeting MUC1-C Showed Anti-Metastasis and Growth-Inhibitory Effects on Human Breast Cancer Cells.新型靶向 MUC1-C 的抗体对人乳腺癌细胞显示出抗转移和生长抑制作用。
Int J Mol Sci. 2020 May 5;21(9):3258. doi: 10.3390/ijms21093258.
7
Mucin-1 is required for Coxsackie Virus B3-induced inflammation in pancreatitis.黏蛋白 1 对于柯萨奇病毒 B3 诱导的胰腺炎炎症反应是必需的。
Sci Rep. 2019 Jul 23;9(1):10656. doi: 10.1038/s41598-019-46933-y.
8
Mechanism of anticancer action of novel berenil complex of platinum(II) combined with anti-MUC1 in MCF-7 breast cancer cells.新型铂(II)与抗MUC1结合的贝尼尔复合物在MCF-7乳腺癌细胞中的抗癌作用机制
Oncol Lett. 2018 Feb;15(2):2340-2348. doi: 10.3892/ol.2017.7623. Epub 2017 Dec 14.
9
Raman-Encoded Molecular Imaging with Topically Applied SERS Nanoparticles for Intraoperative Guidance of Lumpectomy.用于保乳手术术中引导的经局部应用表面增强拉曼散射纳米颗粒的拉曼编码分子成像
Cancer Res. 2017 Aug 15;77(16):4506-4516. doi: 10.1158/0008-5472.CAN-17-0709. Epub 2017 Jun 14.
10
Unraveling the Receptor-Ligand Interactions between Bladder Cancer Cells and the Endothelium Using AFM.利用原子力显微镜揭示膀胱癌细胞与内皮细胞之间的受体-配体相互作用
Biophys J. 2017 Mar 28;112(6):1246-1257. doi: 10.1016/j.bpj.2017.01.033.